Charles River Laboratories | CRL - Current Liabilities



Charles River Laboratories reported $1.08B in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Agilent USD 1.89B 120M Jul/2025
Align Technology USD 2B 4.54M Jun/2025
Bio-Rad Laboratories USD 548.9M 42.3M Jun/2025
Bruker USD 1.35B 2.5M Jun/2025
Cardinal Health USD 38.9B 2.24B Jun/2025
Charles River Laboratories USD 1.08B 29.38M Jun/2025
Cigna USD 56.78B 1.03B Jun/2025
CVS Health USD 94.16B 5.2B Jun/2025
Danaher USD 6.79B 147M Jun/2025
Dentsply International USD 1.17B 627M Jun/2025
Elevance Health 43.83B 1.14B Jun/2025
Galapagos EUR 402.95M 34.09M Jun/2025
Hologic USD 962.5M 27.2M Jun/2025
Humana 18.04B 1.1B Mar/2025
Illumina USD 1.46B 21M Jun/2025
Incyte USD 1.28B 608.18M Jun/2025
IQVIA Holdings USD 7.57B 393M Jun/2025
Laboratory Of America USD 2.72B 652.2M Jun/2025
Lonza CHF 3.58B 970M Dec/2024
McKesson USD 64.33B 2.73B Jun/2025
Merck EUR 9.86B 357M Jun/2025
Mettler Toledo International USD 1.11B 42.8M Jun/2025
Novartis USD 31.71B 95M Jun/2025
Pfizer USD 37.73B 1.27B Jun/2025
Quest Diagnostics USD 2.02B 583M Jun/2025
Revvity USD 671.81M 23.63M Jun/2025
Thermo Fisher Scientific USD 12.72B 456M Jun/2025
United Therapeutics USD 527.1M 194.4M Jun/2025
UnitedHealth 113.47B 9.7B Mar/2025
Waters USD 1.02B 55.16M Jun/2025
West Pharmaceutical Services USD 604.6M 77.9M Jun/2025